欢迎您!
东篱公司
退出
申报数据库
申报指南
立项数据库
成果数据库
期刊论文
会议论文
著 作
专 利
项目获奖数据库
位置:
成果数据库
>
期刊
> 期刊详情页
In vitro pharmacological characterization of TKI-28, a broad-spectrum tyrosine kinase inhibitor with
期刊名称:Cancer Biol Ther 4(10),2005
时间:0
作者或编辑:3448
第一作者所属机构:中国科学院上海药物研究所
页码:1125-1132
语言:英文
相关项目:药理学
作者:
Guo XN.|Zhong L.|Tan JZ.|Li J.|Luo XM.|Jiang HL.|Nan FJ.|Lin LM.|Zhang XW.|Ding J|
同期刊论文项目
药理学
期刊论文 11
会议论文 1
同项目期刊论文
Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1α by promoting protea
Anti-angiogenic effects of shiraiachrome A, a compound isolated from a Chinese folk medicine used to
Evaluation of active recombinant catalytic domain of human ErbB-2 tyrosine kinase and suppression of
Antiangiogenic activity of 11,11’-dideoxyverticillin, a natural product isolated from the fungus Shi
PE, a new sulphated saponin from sea cucumber, exhibits anti-angiogetic and anti-tumor activities in
Philinopside A, a novel marine-derived compound possessing dual anti-angiogenic and anti-tumor effec
11,11’-dideoxy-verticillin, a natural compound possessing growth factor receptor tyrosine kinases in
The p53 pathway is synergized by p38 MAPK signaling to mediate 11,11’-dideoxyverticillin-induced G2/
整合素的活化调控
基底膜和肿瘤转移